These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6266967)

  • 1. Polymyxin B inactivation of lipopolysaccharide in vaccines of Gram-negative bacteria.
    Cooperstock M; Riegle L
    Infect Immun; 1981 Jul; 33(1):315-8. PubMed ID: 6266967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of gram-negative bacteria to the synergistic bactericidal action of serum and polymyxin B nonapeptide.
    Viljanen P; Käyhty H; Vaara M; Vaara T
    Can J Microbiol; 1986 Jan; 32(1):66-9. PubMed ID: 3008971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effect of polymyxin B on pertussis vaccine.
    Larter WE; Corrigan JJ; Fulginiti VA
    Am J Dis Child; 1984 Mar; 138(3):281-3. PubMed ID: 6322572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B.
    Cohen J; McConnell JS
    Eur J Clin Microbiol; 1986 Feb; 5(1):13-7. PubMed ID: 3009177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogenic response of mouse spleen cells and gelation of limulus lysate by lipopolysaccharide of Yersinia pestis and evidence for neutralization of lipopolysaccharide by polymyxin B.
    Butler T; Möller G
    Infect Immun; 1977 Nov; 18(2):400-4. PubMed ID: 200563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyxin B sulfate modification of bacterial endotoxin: effects on the development of endotoxin shock in dogs.
    From AH; Fong JS; Good RA
    Infect Immun; 1979 Mar; 23(3):660-4. PubMed ID: 222676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DNA synthesis and antibody formation in spleen cells of the mouse after in vivo immunization by Escherichia coli lipopolysaccharide modified by polymyxin B].
    Dufer J; Benoist H; Choppin J; Desplaces A
    C R Seances Acad Sci D; 1980 Mar; 290(11):699-701. PubMed ID: 6247077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MvfR Controls Tolerance to Polymyxin B by Regulating
    Yang F; Zhou Y; Bai Y; Pan X; Ha UH; Cheng Z; Wu W; Jin Y; Bai F
    Microbiol Spectr; 2023 Jun; 11(3):e0042623. PubMed ID: 37039709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. II. Complement activating property of the lipopolysaccharide portion and the inhibition by polymyxin B.
    Inada K
    Jpn J Exp Med; 1980 Apr; 50(2):107-15. PubMed ID: 6256561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of gram-negative bacteria to polymyxin B nonapeptide.
    Viljanen P; Vaara M
    Antimicrob Agents Chemother; 1984 Jun; 25(6):701-5. PubMed ID: 6331296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing cell activation and cytokine release in serum-supplemented cultures: methodical note concerning polymyxin B.
    Flegel WA; Rich IN; Schilling ML; Northoff H
    Eur J Haematol; 1989 Oct; 43(4):359-60. PubMed ID: 2555215
    [No Abstract]   [Full Text] [Related]  

  • 12. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lethal effect of complement and lysozyme on polymyxin-treated, serum-resistant gram-negative bacilli.
    Fierer J; Finley F
    J Infect Dis; 1979 Oct; 140(4):581-9. PubMed ID: 229175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-disorganizing property of polymyxin B nonapeptide.
    Lam C; Hildebrandt J; Schütze E; Wenzel AF
    J Antimicrob Chemother; 1986 Jul; 18(1):9-15. PubMed ID: 3019982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro inhibition of lipopolysaccharide-induced bone resorption by polymyxin B.
    Harvey W; Wilson M; Meghji S
    Br J Exp Pathol; 1986 Oct; 67(5):699-705. PubMed ID: 3024692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyxin and pertussis.
    Bannatyne RM
    Am J Dis Child; 1984 Dec; 138(12):1158. PubMed ID: 6095648
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolomics Study of the Synergistic Killing of Polymyxin B in Combination with Amikacin against Polymyxin-Susceptible and -Resistant Pseudomonas aeruginosa.
    Hussein M; Han ML; Zhu Y; Zhou Q; Lin YW; Hancock REW; Hoyer D; Creek DJ; Li J; Velkov T
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance.
    Moore RA; Hancock RE
    Antimicrob Agents Chemother; 1986 Dec; 30(6):923-6. PubMed ID: 3028253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin B suppresses the endotoxin inhibition of concanavalin a-mediated erythrocyte agglutination.
    Warren JR
    Infect Immun; 1982 Feb; 35(2):594-9. PubMed ID: 6276306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the binding of gram-negative bacterial endotoxin by polymyxin B sulphate, colistin sulphate and colistin sulphomethate sodium.
    Rogers MJ; Cohen J
    Infection; 1986; 14(2):79-81. PubMed ID: 3011678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.